Test Compounds | Uptake | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
pH 7.4 | pH 5.0 | ||||||||||
Mock | OATP-B | OATP-B-specific | Mock | OATP-B | OATP-B-specific | ||||||
μl/mg protein | |||||||||||
[14C]Acetic acid (4.94 μM) | 15.5 ± 0.41 | 18.3 ± 1.00 | 2.81 ± 1.00 | 77.2 ± 2.04 | 81.7 ± 5.63 | 4.50 ± 5.63 | |||||
[3H]DHEAS (2.98 nM) | 138 ± 5.55 | 214 ± 5.19* | 76.4 ± 5.19 | 230 ± 3.43 | 443 ± 2.63* | 213 ± 2.63 | |||||
[3H]E13S (5.43 nM) | 141 ± 5.59 | 237 ± 6.78* | 96.0 ± 6.78 | 173 ± 3.34 | 483 ± 3.67* | 310 ± 3.67 | |||||
[3H]E217βG (5.72 nM) | 39.2 ± 2.01 | 38.5 ± 1.81 | -0.68 ± 1.81 | 53.3 ± 1.86 | 58.6 ± 1.93 | 5.31 ± 1.93 | |||||
Fexofenadine (10 μM) | 51.7 ± 1.07 | 58.5 ± 1.00* | 6.82 ± 1.00 | 117 ± 3.79 | 140 ± 2.66* | 23.7 ± 2.66 | |||||
[14C]Lactic acid (1.91 μM) | 9.41 ± 0.82 | 10.3 ± 0.93 | 0.84 ± 0.93 | 119 ± 1.93 | 120 ± 1.66 | 1.17 ± 1.66 | |||||
[14C]Pravastatin (14.7 μM) | 3.99 ± 0.37 | 4.44 ± 0.46 | 0.44 ± 0.46 | 72.1 ± 1.33 | 92.4 ± 1.86* | 20.3 ± 1.86 | |||||
[3H]TCA (0.15 μM) | 32.5 ± 1.06 | 35.4 ± 1.28 | 3.28 ± 1.28 | 40.4 ± 1.04 | 53.5 ± 1.35* | 13.1 ± 1.35 |
DHEAS, dehydroepiandrosterone sulfate; E13S, estrone-3-sulfate; E217βG, estradiol-17β-glucuronide; TCA, taurocholic acid.
OATP-B-cDNA-transfected or mock cells were preloaded for 20 min at 37°C in the incubation medium (pH 7.4).
↵* indicates a significant difference from the uptake of mock-transfected cells (p < 0.05).